MSFT 430.95 1.7688% AAPL 239.625 0.967% NVDA 137.9692 -0.2031% GOOGL 172.05 1.8349% GOOG 173.58 1.8124% AMZN 210.79 1.395% META 593.04 3.2595% AVGO 166.86 2.9492% TSLA 357.2187 3.4937% TSM 194.225 5.1798% LLY 801.2078 0.7365% V 315.94 0.2729% JPM 246.3 -1.3695% UNH 607.76 -0.3999% NVO 108.925 1.9897% WMT 92.555 0.0595% LVMUY 127.99 2.9686% XOM 117.79 -0.1441% LVMHF 645.0 3.8221% MA 530.27 -0.501%
Last update at 2024-12-02T20:47:00Z
Is Immunovant, Inc. (IMVT) the Worst Performing Stock to Buy on the Dip?
Tue 01 Oct 24, 01:58 PMIs Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $50 To Buy?
Mon 30 Sep 24, 03:12 PMIMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
Mon 09 Sep 24, 12:35 PMAre Investors Undervaluing Immunovant, Inc. (NASDAQ:IMVT) By 46%?
Mon 02 Sep 24, 10:48 AMQ1 2025 Roivant Sciences Ltd Earnings Call
Fri 09 Aug 24, 04:20 AMWe Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth
Tue 23 Jul 24, 01:37 PMDianthus (DNTH) Gains 18% in the Past Month: Here's Why
Mon 08 Jul 24, 03:06 PM| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | -210.95100M | -156.81400M | -107.78900M | -66.29100M | -0.00045M |
| Minority interest | - | - | - | - | - |
| Net income | -210.96000M | -156.73000M | -107.43100M | -66.38800M | -0.00045M |
| Selling general administrative | 48.02M | 54.23M | 39.51M | 18.15M | 2.69M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | - | - | - | - | - |
| Reconciled depreciation | 0.19M | 0.13M | 0.07M | 0.02M | - |
| Ebit | -198.46900M | -156.15900M | -107.78900M | -65.66600M | -0.00045M |
| Ebitda | -198.27600M | -156.03300M | -107.72400M | -65.64500M | -0.00045M |
| Depreciation and amortization | 0.19M | 0.13M | 0.07M | 0.02M | - |
| Non operating income net other | -0.25300M | -0.78100M | 0.33M | - | - |
| Operating income | -198.46900M | -156.15900M | -107.78900M | -65.66600M | -0.00045M |
| Other operating expenses | 208.28M | 156.03M | 108.12M | 66.08M | 0.00045M |
| Interest expense | 12.48M | 0.66M | 0.00000M | 0.62M | 0.00000M |
| Tax provision | 0.00900M | -0.08400M | -0.35800M | 0.10M | - |
| Interest income | 7.58M | - | - | 0.62M | - |
| Net interest income | 7.58M | - | 0.00000M | -0.62500M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | 10.00M | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.00900M | -0.08400M | -0.35800M | 0.10M | 0.02M |
| Total revenue | 0.00000M | 0.00000M | 0.00000M | 0.00000M | - |
| Total operating expenses | 208.28M | 156.03M | 108.12M | 66.08M | 0.00045M |
| Cost of revenue | - | - | - | - | - |
| Total other income expense net | -12.48200M | -0.65500M | 0.33M | -0.62500M | -0.15548M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -210.96000M | -156.73000M | -107.43100M | -66.38800M | -28.59942M |
| Net income applicable to common shares | -210.96000M | -156.73000M | -107.43100M | -66.38800M | -28.59900M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Total assets | 405.84M | 515.56M | 412.49M | 109.39M | 0.41M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 26.92M | 6.25M | 8.31M | 5.46M | 0.08M |
| Total liab | 43.34M | 45.74M | 21.01M | 15.32M | 0.38M |
| Total stockholder equity | 362.49M | 469.82M | 391.48M | 94.07M | 0.02M |
US 
AU
UK
CA
NZ